| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |